Clinical Trials Directory

Trials / Completed

CompletedNCT01290796

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
153 (actual)
Sponsor
C. R. Bard · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the overall effectiveness of the Ajust Adjustable Single-Incision Sling in the surgical treatment of female stress urinary incontinence.

Detailed description

Urinary incontinence (UI), or the complaint of any involuntary loss of urine, ranges in severity from the occasional leaking urine during actions resulting in increased abdominal pressure (coughing, sneezing, laughing, exercise, etc.) to sudden, unpredictable strong urges to void. Female stress urinary incontinence (SUI) is attributed to a weakening of the pelvic floor muscles. A recent review of literature describing the prevalence of UI calculated the median prevalence of female UI to be 27.6% (4.8-58.4%), with the prevalence of significant incontinence increasing with age. The prevalent cause of UI was further categorized into stress (50%), mixed (32%) and urge (14%). Nonsurgical treatment of female SUI has traditionally been limited to alpha-adrenergic agonists and estrogens, pelvic floor exercises, biofeedback, electrical stimulation and behavior modification1. Options for surgical treatment consists of periurethral injections of bulking agents, transvaginal suspensions, retropubic suspensions, slings and sphincter prostheses. The Ajust™ Adjustable Single-Incision Sling is a fully adjustable single-incision sling that anchors in the transobturator membranes, anatomically sufficient spaces for support of the urethra.

Conditions

Interventions

TypeNameDescription
DEVICEAjust Adjustable Single-Incision SlingThe Ajust™ Adjustable Single-Incision Sling is a minimally invasive suburethral sling indicated for the treatment of female SUI resulting from urethral hypermobility and/or intrinsic sphincter deficiency (ISD). The system consists of a unique adjustable polypropylene mesh sling with permanent, self-fixating, polypropylene anchors, an introducer, and a flexible stylet for securing the mesh sling after adjustment.

Timeline

Start date
2011-01-01
Primary completion
2013-06-01
Completion
2015-10-01
First posted
2011-02-07
Last updated
2017-03-27
Results posted
2014-05-12

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01290796. Inclusion in this directory is not an endorsement.